Treatment outcomes of standard (high dose) cisplatin and non‐standard chemotherapy for locally advanced head and neck cancer

Treatment outcomes of standard (high dose) cisplatin and non‐standard chemotherapy for locally advanced head and neck cancer

Abstract Introduction Concurrent chemoradiotherapy with high‐dose (HD) cisplatin is the standard treatment for locally advanced head and neck squamous cell carcinoma (LA‐HNSCC). Due to the higher treatment‐related adverse effects with standard therapy, alternative regimens (non‐standard therapy), na...

Full description

Bibliographic Details
Main Authors: Muhammad Alamgeer, Andrew Coleman, Lachlan McDowell, Charles Giddings, Adnan Safdar, Elizabeth Sigston, Yang Wang, Ashwin Subramaniam
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Reports
Subjects:
carboplatin/paclitaxel
cetuximab
cisplatin
locally advanced head and neck cancer
toxicity
Online Access:https://doi.org/10.1002/cnr2.1674

Internet

https://doi.org/10.1002/cnr2.1674

Similar Items